Terms: = Cervical cancer AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB AND Clinical Outcome
11 results:
1. egfr Promoter Methylation, egfr Mutation, and HPV Infection in Chinese cervical Squamous Cell Carcinoma.
Zhang W; Jiang Y; Yu Q; Qiang S; Liang P; Gao Y; Zhao X; Liu W; Zhang J
Appl Immunohistochem Mol Morphol; 2015 Oct; 23(9):661-6. PubMed ID: 25789535
[TBL] [Abstract] [Full Text] [Related]
2. Tissue biomarkers as prognostic variables of cervical cancer.
Gadducci A; Guerrieri ME; Greco C
Crit Rev Oncol Hematol; 2013 May; 86(2):104-29. PubMed ID: 23031678
[TBL] [Abstract] [Full Text] [Related]
3. Membranous expression of ectodomain isoforms of the epidermal growth factor receptor predicts outcome after chemoradiotherapy of lymph node-negative cervical cancer.
Halle C; Lando M; Svendsrud DH; Clancy T; Holden M; Sundfør K; Kristensen GB; Holm R; Lyng H
Clin Cancer Res; 2011 Aug; 17(16):5501-12. PubMed ID: 21737508
[TBL] [Abstract] [Full Text] [Related]
4. Phase II study of cisplatin plus cetuximab in advanced, recurrent, and previously treated cancers of the cervix and evaluation of epidermal growth factor receptor immunohistochemical expression: a Gynecologic Oncology Group study.
Farley J; Sill MW; Birrer M; Walker J; Schilder RJ; Thigpen JT; Coleman RL; Miller BE; Rose PG; Lankes HA
Gynecol Oncol; 2011 May; 121(2):303-8. PubMed ID: 21329967
[TBL] [Abstract] [Full Text] [Related]
5. Genetic heterogeneity of egfr mutation in pleomorphic carcinoma of the lung: response to gefitinib and clinical outcome.
Ushiki A; Koizumi T; Kobayashi N; Kanda S; Yasuo M; Yamamoto H; Kubo K; Aoyagi D; Nakayama J
Jpn J Clin Oncol; 2009 Apr; 39(4):267-70. PubMed ID: 19155283
[TBL] [Abstract] [Full Text] [Related]
6. Gene profiling in Pap-cell smears of high-risk human papillomavirus-positive squamous cervical carcinoma.
Manavi M; Hudelist G; Fink-Retter A; Gschwandtler-Kaulich D; Pischinger K; Czerwenka K
Gynecol Oncol; 2007 May; 105(2):418-26. PubMed ID: 17306351
[TBL] [Abstract] [Full Text] [Related]
7. Oncogene expression and microvessel count in recurrent and nonrecurrent stage Ib squamous cell carcinoma of the cervix.
Hove MG; Dinh TV; Hannigan EV; Lucci JA; Chopra V; Smith ER; To T
J Reprod Med; 1999 Jun; 44(6):493-6. PubMed ID: 10394542
[TBL] [Abstract] [Full Text] [Related]
8. Tumour-proliferative fraction and growth factor expression as markers of tumour response to radiotherapy in cancer of the uterine cervix.
Pillai MR; Jayaprakash PG; Nair MK
J Cancer Res Clin Oncol; 1998; 124(8):456-61. PubMed ID: 9750023
[TBL] [Abstract] [Full Text] [Related]
9. c-erbb-2 oncoprotein and epidermal growth factor receptor in cervical lesions.
Lakshmi S; Nair MB; Jayaprakash PG; Rajalekshmy TN; Nair MK; Pillai MR
Pathobiology; 1997; 65(3):163-8. PubMed ID: 9309783
[TBL] [Abstract] [Full Text] [Related]
10. c-erbb-2 oncoprotein overexpression in uterine cervix carcinoma with glandular differentiation. A frequent event but not an independent prognostic marker because it occurs late in the disease.
Costa MJ; Walls J; Trelford JD
Am J Clin Pathol; 1995 Dec; 104(6):634-42. PubMed ID: 8526205
[TBL] [Abstract] [Full Text] [Related]
11. [EGF receptor and EGF-like activity as prognostic factors in cervix cancer].
Stellwag B; Scheidel P; Pfeiffer D; Hepp H
Geburtshilfe Frauenheilkd; 1993 Mar; 53(3):177-81. PubMed ID: 8467984
[TBL] [Abstract] [Full Text] [Related]
